Who
Bart Friedman
Director
Company insider
Files Form 4 as: Director, Ovid Therapeutics; Director, Allied World Assurance Co Holdings, AG.
In numbers
- Trades disclosed
- 36
- Buys
- 1
- Sells
- 0
- Bought
- $68K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 11 Jul 2006
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | OVID Ovid TherapeuticsBiotechnology | SEC FORM 4 Code A | $22K8,789 at $2.56 | filing |
| 7 Apr 2026filed 9 Apr 2026 | OVID Ovid TherapeuticsBiotechnology | SEC FORM 4 Code A | $22K8,789 at $2.56 | filing |
| 26 Feb 2026filed 2 Mar 2026 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 20 Feb 2025filed 18 Jun 2025 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 12 Dec 2024filed 16 Dec 2024 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 23 Feb 2023filed 27 Feb 2023 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 8 Apr 2022filed 12 Apr 2022 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,424 at $0.00 | filing |
| 3 Feb 2022filed 4 Feb 2022 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 11 Jun 2021filed 11 Jun 2021 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 17 May 2021filed 18 May 2021 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,750 at $0.00 | filing |
| 5 Jun 2020filed 8 Jun 2020 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,250 at $0.00 | filing |
| 13 Nov 2019filed 15 Nov 2019 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,437 at $0.00 | filing |
| 10 Jun 2019filed 2 Aug 2019 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,813 at $0.00 | filing |
| 7 Jun 2018filed 8 Jun 2018 | OVID Ovid Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,813 at $0.00 | filing |
| 6 Jul 2017filed 10 Jul 2017 | Allied World Assurance Co Holdings, AG | SEC FORM 4 Code U | —43,727 | filing |
| 22 Feb 2017filed 24 Feb 2017 | Allied World Assurance Co Holdings, AG | SEC FORM 4 Code F | $29K548 at $53.12 | filing |
| 22 Feb 2016filed 24 Feb 2016 | Allied World Assurance Co Holdings, AG | SEC FORM 4 Code A | —2,737 at $0.00 | filing |
| 17 Feb 2016filed 19 Feb 2016 | Allied World Assurance Co Holdings, AG | SEC FORM 4 Code F | $14K463 at $31.04 | filing |
News
No headline names them, or the companies they trade most, lately.